ALKBH5 inhibitor therapy(HOIST)

N/A

Report date: 2024/04/30 13:52:25
NME

Base Information

Drug NameALKBH5 inhibitor therapy(HOIST)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA demethylase ALKBH5 inhibitors
TargetsRNA demethylase ALKBH5
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHOIST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHOIST Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A